» Articles » PMID: 7202083

Calculation of Free and Bound Fractions of Testosterone and Estradiol-17 Beta to Human Plasma Proteins at Body Temperature

Overview
Specialty Biochemistry
Date 1982 Jun 1
PMID 7202083
Citations 363
Authors
Affiliations
Soon will be listed here.
Abstract

A mathematical model for the calculation of free and protein bound concentrations of testosterone and estradiol in plasma is presented. The method is based on the knowledge of the total concentrations of all steroids competing for the same binding site on testosterone-estradiol-binding globulin (TeBG), the concentration of albumin, the binding capacity of TeBG, and the association constants of the steroids to the two binding proteins. For the calculations we have determined the total concentrations of testosterone and estradiol. TeBG binding capacity, albumin concentration and the association constants for the binding of testosterone, estradiol and 5 alpha-dihydrotestosterone (DHT) to TeBG and albumin at 37 degrees C. Physiological concentrations of some androgen metabolites reported in the literature were also included in the calculations, namely: DHT, 5-androstene-3 beta, 17 beta-diol (Ae) and 5 alpha-androstane-3 alpha, 17 beta-diol (Aa). The binding constants for Ae and Aa to TeBG and albumin were also from the literature. Mean values of testosterone were calculated for 11 normal men and expressed as percentages of total: 2.0% was unbound, 53--55% bound to albumin and 43--45% bound to TeBG. For 16 normal women of a fertile age the corresponding values were 1.5%, 36--37% and 62%. For estradiol they were 2.4% 68--70% and 28--30% in the men and 2.0%, 52% and 45--46% in the women. Variations in the concentrations of DHT. Ae and Aa did not influence the free concentrations of testosterone and estradiol to any significant extent. It was furthermore concluded that the androgen metabolites could be omitted from the calculations without affecting the calculated concentrations.

Citing Articles

Prospective Analysis of Circulating Biomarkers and Ovarian Cancer Risk in the UK Biobank.

Sasamoto N, Hathaway C, Townsend M, Terry K, Trabert B, Tworoger S Cancer Epidemiol Biomarkers Prev. 2024; 33(10):1347-1355.

PMID: 39007864 PMC: 11446659. DOI: 10.1158/1055-9965.EPI-24-0319.


Levels of Sex Hormones and Abdominal Muscle Composition in Men from The Multi-Ethnic Study of Atherosclerosis.

Osmancevic A, Allison M, Miljkovic I, Vella C, Ouyang P, Trimpou P Sci Rep. 2024; 14(1):16114.

PMID: 38997435 PMC: 11245501. DOI: 10.1038/s41598-024-66948-4.


Menopause and Estrogen Associations With Gut Barrier, Microbial Translocation, and Immune Activation Biomarkers in Women With and Without HIV.

Peters B, Hanna D, Xue X, Weber K, Appleton A, Kassaye S J Acquir Immune Defic Syndr. 2024; 96(3):214-222.

PMID: 38905473 PMC: 11196004. DOI: 10.1097/QAI.0000000000003419.


Sex-steroid hormones and risk of postmenopausal estrogen receptor-positive breast cancer: a case-cohort analysis.

Albers F, Lou M, Dashti S, Swain C, Rinaldi S, Viallon V Cancer Causes Control. 2024; 35(6):921-933.

PMID: 38363402 PMC: 11130059. DOI: 10.1007/s10552-024-01856-6.


The assessment of liver function test and fertility hormones in Saudi athletes using anabolic androgenic steroids.

Jambi S, Mirza A, Zughaibi T, Khalil H, Borai A Saudi Pharm J. 2024; 32(2):101954.

PMID: 38292405 PMC: 10825542. DOI: 10.1016/j.jsps.2024.101954.